Corcept Therapeutics Inc (NASDAQ:CORT)

16.06
Delayed Data
As of Jun 22
 -0.48 / -2.90%
Today’s Change
11.50
Today|||52-Week Range
25.96
-11.07%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$2.0B

Company Description

Corcept Therapeutics, Inc. engages in the development of drugs for the treatment of severe psychiatric, neurological, and metabolic disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.

Contact Information

Corcept Therapeutics, Inc.
149 Commonwealth Drive
Menlo Park California 94025
P:(650) 327-3270
Investor Relations:
(650) 688-8783

Employees

Shareholders

Mutual fund holders40.51%
Other institutional36.43%
Individual stakeholders30.72%

Top Executives

Joseph K. BelanoffPresident, Chief Executive Officer, Director & MD
Gary Charles RobbSecretary & Chief Financial Officer
Hazel HuntSenior Vice President-Research
Robert S. FishmanChief Medical Officer
Sean MaduckSenior Vice President-Commercial